Cargando…

The epidemiology and clinical feature of selective immunoglobulin a deficiency of Zhejiang Province in China

BACKGROUND: Selective immunoglobulin A deficiency (SIgAD) is the most common primary antibody deficiency disease and frequently reported in the Western countries. However, large‐scale epidemiologic studies on SIgAD in China are still lacking. METHODS: The clinical information of 555 180 subjects (ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Junwu, Kong, Wanzhong, Ni, Jinyao, Guo, Zhen, Yang, Xunjun, Cao, Qun, Wang, Sheliang, Feng, Yijun, Zhou, Ying, Weng, Wei, Liang, Shanyan, Li, Shuang, Chen, Yanxia, Liu, Jinlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595911/
https://www.ncbi.nlm.nih.gov/pubmed/32715518
http://dx.doi.org/10.1002/jcla.23440
_version_ 1783601988741627904
author Zhang, Junwu
Kong, Wanzhong
Ni, Jinyao
Guo, Zhen
Yang, Xunjun
Cao, Qun
Wang, Sheliang
Feng, Yijun
Zhou, Ying
Weng, Wei
Liang, Shanyan
Li, Shuang
Chen, Yanxia
Liu, Jinlin
author_facet Zhang, Junwu
Kong, Wanzhong
Ni, Jinyao
Guo, Zhen
Yang, Xunjun
Cao, Qun
Wang, Sheliang
Feng, Yijun
Zhou, Ying
Weng, Wei
Liang, Shanyan
Li, Shuang
Chen, Yanxia
Liu, Jinlin
author_sort Zhang, Junwu
collection PubMed
description BACKGROUND: Selective immunoglobulin A deficiency (SIgAD) is the most common primary antibody deficiency disease and frequently reported in the Western countries. However, large‐scale epidemiologic studies on SIgAD in China are still lacking. METHODS: The clinical information of 555 180 subjects (age >4 years) including the outpatient, inpatient, and healthy subjects who had ordered serum immunoglobulin A, G, M in 9 hospitals of Zhejiang Province in China was collected. The SIgAD individuals were defined as IgA level <0.07 g/L with normal levels of serum IgG and IgM, whose age should be over 4 years, and any other secondary diseases causing SIgAD were also excluded. Then, the geographical and prevalence distribution of SIgAD individuals in Zhejiang Province and patients' clinical characteristics at the time of diagnosis were also reviewed. RESULT: Among these 555 180 subjects who had ordered the immunoglobulin evaluation, the prevalence of SIgAD was 109/555180 (0.02%). The ratio of male to female of these SIgAD individuals was 1:1.37, which also included 87 adults (≥18 years) and 22 children (18 > age >4 years). For adults, the common clinical features were infections (43/87, 49.43%), autoimmune disorders (31/87, 35.63%), allergic cases (5/87, 5.75%), and tumor cases (4/87, 4.60%). Additionally, infectious diseases (20/22, 90.91%), autoimmune disorders (4/22, 18.18%), and allergic cases (1/22, 4.55%) were found in 22 children. CONCLUSION: We first describe a large cohort of SIgAD individuals of Zhejiang Province in China. The incidence was 0.020%. The common clinical features were infection, autoimmune disorders, tumor, and allergy, and the infection rate was higher in children than the adults.
format Online
Article
Text
id pubmed-7595911
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75959112020-11-02 The epidemiology and clinical feature of selective immunoglobulin a deficiency of Zhejiang Province in China Zhang, Junwu Kong, Wanzhong Ni, Jinyao Guo, Zhen Yang, Xunjun Cao, Qun Wang, Sheliang Feng, Yijun Zhou, Ying Weng, Wei Liang, Shanyan Li, Shuang Chen, Yanxia Liu, Jinlin J Clin Lab Anal Research Articles BACKGROUND: Selective immunoglobulin A deficiency (SIgAD) is the most common primary antibody deficiency disease and frequently reported in the Western countries. However, large‐scale epidemiologic studies on SIgAD in China are still lacking. METHODS: The clinical information of 555 180 subjects (age >4 years) including the outpatient, inpatient, and healthy subjects who had ordered serum immunoglobulin A, G, M in 9 hospitals of Zhejiang Province in China was collected. The SIgAD individuals were defined as IgA level <0.07 g/L with normal levels of serum IgG and IgM, whose age should be over 4 years, and any other secondary diseases causing SIgAD were also excluded. Then, the geographical and prevalence distribution of SIgAD individuals in Zhejiang Province and patients' clinical characteristics at the time of diagnosis were also reviewed. RESULT: Among these 555 180 subjects who had ordered the immunoglobulin evaluation, the prevalence of SIgAD was 109/555180 (0.02%). The ratio of male to female of these SIgAD individuals was 1:1.37, which also included 87 adults (≥18 years) and 22 children (18 > age >4 years). For adults, the common clinical features were infections (43/87, 49.43%), autoimmune disorders (31/87, 35.63%), allergic cases (5/87, 5.75%), and tumor cases (4/87, 4.60%). Additionally, infectious diseases (20/22, 90.91%), autoimmune disorders (4/22, 18.18%), and allergic cases (1/22, 4.55%) were found in 22 children. CONCLUSION: We first describe a large cohort of SIgAD individuals of Zhejiang Province in China. The incidence was 0.020%. The common clinical features were infection, autoimmune disorders, tumor, and allergy, and the infection rate was higher in children than the adults. John Wiley and Sons Inc. 2020-07-26 /pmc/articles/PMC7595911/ /pubmed/32715518 http://dx.doi.org/10.1002/jcla.23440 Text en © 2020 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Zhang, Junwu
Kong, Wanzhong
Ni, Jinyao
Guo, Zhen
Yang, Xunjun
Cao, Qun
Wang, Sheliang
Feng, Yijun
Zhou, Ying
Weng, Wei
Liang, Shanyan
Li, Shuang
Chen, Yanxia
Liu, Jinlin
The epidemiology and clinical feature of selective immunoglobulin a deficiency of Zhejiang Province in China
title The epidemiology and clinical feature of selective immunoglobulin a deficiency of Zhejiang Province in China
title_full The epidemiology and clinical feature of selective immunoglobulin a deficiency of Zhejiang Province in China
title_fullStr The epidemiology and clinical feature of selective immunoglobulin a deficiency of Zhejiang Province in China
title_full_unstemmed The epidemiology and clinical feature of selective immunoglobulin a deficiency of Zhejiang Province in China
title_short The epidemiology and clinical feature of selective immunoglobulin a deficiency of Zhejiang Province in China
title_sort epidemiology and clinical feature of selective immunoglobulin a deficiency of zhejiang province in china
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595911/
https://www.ncbi.nlm.nih.gov/pubmed/32715518
http://dx.doi.org/10.1002/jcla.23440
work_keys_str_mv AT zhangjunwu theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT kongwanzhong theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT nijinyao theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT guozhen theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT yangxunjun theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT caoqun theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT wangsheliang theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT fengyijun theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT zhouying theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT wengwei theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT liangshanyan theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT lishuang theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT chenyanxia theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT liujinlin theepidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT zhangjunwu epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT kongwanzhong epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT nijinyao epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT guozhen epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT yangxunjun epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT caoqun epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT wangsheliang epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT fengyijun epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT zhouying epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT wengwei epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT liangshanyan epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT lishuang epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT chenyanxia epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina
AT liujinlin epidemiologyandclinicalfeatureofselectiveimmunoglobulinadeficiencyofzhejiangprovinceinchina